Table 1 Hoarding Disorder Participant Characteristics.

From: Anosognosia in hoarding disorder is predicted by alterations in cognitive and inhibitory control

Demographic and clinical variables

Full sample (n = 71)

Neurocognitive testing subset (n = 53)

Age, mean (range, ± SD)

57.0 (24–75; ± 10.4)

57.0 (24–75; ± 10.4)

Gendera, n (%)

Female

53 (75)

41 (77)

Male

18 (25)

12 (23)

Non-binary/other

0 (0)

0 (0)

Racea, n (%)

Caucasian/White

53 (75)

41 (77)

African American/Black

3 (4)

1 (2)

Asian

10 (14)

7 (13)

Native Hawaiian/Pacific Islander

1 (1)

1 (2)

Other/Did not endorse

4 (6)

3 (6)

Ethnicitya, n (%)

Hispanic

3 (4)

2 (4)

Non-Hispanic

67 (94)

50 (94)

Did not endorse

1 (1)

1 (2)

DSM-5 comorbidity (current), n (%)

Other obsessive-compulsive and related disorder

5 (7.04)

5 (9.43)

Depressive disorder

7 (9.86)

6 (11.32)

Anxiety disorder

6 (8.45)

6 (11.32)

Attention-deficit/hyperactivity disorder

9 (12.68)

9 (17)

Trauma- and stressor-related disorder

4 (5.63)

4 (7.55)

Sleep–wake disorders

9 (12.68)

9 (17)

Otherb

6 (8.45)

6 (11.32)

Psychotropic medication use, n (%)

Any psychotropic medication

40 (60)

28 (53)

Antidepressant

36 (54)

26 (49)

Antipsychotic

3 (5)

3 (6)

Somatic medical comorbidity

Current medical diagnosesc, (mean (range; ± SD))

2.62 (0–8; ± 1.90)

2.57 (0–7; ± 1.82)

Any non-psychotropic medication, n (%)

42 (65)

31 (65)

Clinical measures, mean (range; ± SD)

Saving Inventory-Revised total

59.1 (14–86; ± 10.9)

59.9 (42–86; ± 9.9)

Clutter Image Rating room average, self-rated

3.78 (1.67–6.40; ± 1.14)

3.67 (1.67–6.4; ± 1.12)

Clutter Image Rating room average, independent evaluator-rated

4.22 (1–8.33; ± 1.39)

4.11 (1–6.33; ± 1.17)

Saving Cognitions Inventory total

98.2 (52–150; ± 27.4)

97.5 (52–160; ± 27.2)

Hamilton Depression Rating Scale -17

5.8 (0–24; ± 4.9)

4.8 (0–12; ± 4.0)

Edinburgh Handedness Inventory—laterality quotient

77.9 (-100–100; ± 45.3)

77.3 (-100–100; ± 48.9)

North American Adult Reading Test

115.2 (84.1–123.9; ± 7.3)

116.4 (84.1–123.9; ± 6.1)

  1. aSelf-asserted. bā€˜Other’ includes somatic symptom disorder (n = 3), substance use disorder (n = 2), bipolar and related disorders (n = 1). cSelf-reported diagnoses include the following categories/conditions (% of full sample): endocrine/metabolic (42%); cardiovascular (29%); musculoskeletal (23%), respiratory/allergic (22%), obstructive sleep apnea (17%); neurologic (16%); remitted cancer (14%); gastrointestinal (14%); urogenital (9%); rheumatologic (4%); dermatologic (3%); hematologic (3%).